News from the global scientific community focused on furthering the understanding and treatment of pediculosis, including research and clinical trials.
A new study analysing the effect of human scalp components on the behavior of adult head lice has shown for the first time the effect of host components conditioning on head lice behavior.
A molecular screening of pygmies’ head lice in the Republic of Congo has identified the presence of a dangerous human pathogen, Borrelia reccurentis, the causative agent of relapsing fever, in ten clade A head lice, which was not reported in the republic of Congo and B. theileri in one head louse.
A new study analysing the ancient DNA of head lice and their eggs from the Roman period has revealed that clade B lice existed, at least in the Middle East, prior to contacts between Native Americans and Europeans.
In an effort to control the head lice infestations and drug resistance to the most commonly used head lice treatments, the US Food and Drug Administration (FDA) has issued a new guidance on developing topical drugs.
A summary of several smaller-impact papers on head lice published in 2015.
Two new papers on ivermectin provide evidence for synergistic anti-lice activity when combined with antibiotics.
A review of literature searches and clinical trials on Pediculosis has provided an overview on managing and treating human lice. This review highlights new strategies to more effectively fight pediculoisis and prevent resistance.
A review providing the relevant information on infestation treatments available in the United States has revealed that there is a high risk of failure of over-the-counter treatments in eliminating head lice.
A study testing a neem-extract head lice treatment has found evidence for efficacy in treating head lice infection.
Recent trials for oil-based lice treatments have shown promising results in using physical action to treat lice infections.